InfiniTrak’s Controlled Substance Tracking System (CSTS) provides pharmacies, health systems, and regulators with a statewide, real-time solution to monitor opioid and controlled drug distribution. Built on advanced data analytics and secure reporting, the platform helps organizations maintain DEA and DSCSA compliance while proactively addressing diversion and counterfeit drug risks. Unlike traditional systems that can take weeks or months to identify anomalies, CSTS delivers immediate alerts to pharmacies, regulators, and law enforcement, enabling timely intervention to stop diversion before it escalates. The system also establishes a centralized, interoperable database, giving pharmacies visibility across the drug supply chain and ensuring operations remain secure, transparent, and compliant.
By flagging suspicious activity the same day shipments are delivered—often before dispensers even receive them—InfiniTrak enhances early detection of potential abusers, pill mill activity, and other diversion threats. The platform further strengthens drug supply integrity by creating a secure statewide network of shared data that is efficient, confidential, and accessible for investigative purposes. This proactive approach not only improves patient and community safety but also gives regulators and providers the tools needed to respond swiftly to anomalies, prevent counterfeit infiltration, and reinforce trust in the pharmaceutical supply chain.
Key Advantages of InfiniTrak’s Controlled Substance Tracking include:
- Statewide CSTS
- Real-Time Alerts
- Diversion Prevention
- Real-Time Action
- Advanced Detection
Through advanced detection, automated notifications, and streamlined data analytics, InfiniTrak helps states and healthcare providers anticipate emerging threats to community safety and drug supply integrity.
